Your browser doesn't support javascript.
loading
Efficacy and safety of sodium oxybate in alcohol-dependent patients with a very high drinking risk level.
van den Brink, Wim; Addolorato, Giovanni; Aubin, Henri-Jean; Benyamina, Amine; Caputo, Fabio; Dematteis, Maurice; Gual, Antoni; Lesch, Otto-Michael; Mann, Karl; Maremmani, Icro; Nutt, David; Paille, François; Perney, Pascal; Rehm, Jürgen; Reynaud, Michel; Simon, Nicolas; Söderpalm, Bo; Sommer, Wolfgang H; Walter, Henriette; Spanagel, Rainer.
Afiliación
  • van den Brink W; Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Addolorato G; Alcohol Use Disorder Unit, Department of Internal Medicine, Gastroenterology and Hepatology, Catholic University of Rome, A. Gemelli Hospital, Rome, Italy.
  • Aubin HJ; French Institute of Health and Medical Research, Centre de Recherche en Epidémiologie et Santé des Populations (CESP), Paris, France.
  • Benyamina A; Addiction Research and Treatment Center, Paul Brousse Hospital, Paris-Sud University, Villejuif, France.
  • Caputo F; Addiction Research and Treatment Center, Paul Brousse Hospital, Paris-Sud University, Villejuif, France.
  • Dematteis M; Department of Internal Medicine, SS Annunziata Hospital, Cento (Ferrara), Italy.
  • Gual A; Department of Addiction Medicine, Grenoble-Alpes University Hospital, Genoble, France.
  • Lesch OM; Psychiatry Department, Neurosciences Institute, Hospital Clinic, IDIBAPS, Barcelona, Spain.
  • Mann K; Addiction Medicine, University for Psychiatry and Psychotherapy, Vienna, Austria.
  • Maremmani I; Clinic of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.
  • Nutt D; Santa Chiara University Hospital, University of Pisa, Pisa, Italy.
  • Paille F; Centre for Neuropsychopharmacology, Imperial College London, London, UK.
  • Perney P; Department of Addiction Treatment, University Hospital, Vandoeuvre-lès-Nancy, France.
  • Rehm J; Addiction Medicine, Hospital Grau-du-Roi, Nimes, France.
  • Reynaud M; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Simon N; Dalla Lana School of Public Health & Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
  • Söderpalm B; Clinical Psychology & Psychoterapy Technical University Dresden, Dresden, Germany.
  • Sommer WH; Paris Sud University and Fonds Actions Addictions, Paris, France.
  • Walter H; APHM, INSERM, IRD, SESSTIM, Hop Sainte Marguerite, Department of Clinical Pharmacology, CAP-TV, Aix Marseille Univ, Marseille, France.
  • Spanagel R; Section of Psychiatry and Neurochemistry Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Addict Biol ; 23(4): 969-986, 2018 07.
Article en En | MEDLINE | ID: mdl-30043457

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oxibato de Sodio / Disuasivos de Alcohol / Alcoholismo Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Addict Biol Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oxibato de Sodio / Disuasivos de Alcohol / Alcoholismo Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Addict Biol Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos